LEO Pharma reveal positive results from delgocitinib research by FMR Global | Dec 15, 2022 | FMR GLOBAL | 0 comments Phase 3 clinical trial focuses on adults with moderate-to-severe chronic hand eczema Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
